News
CFDA for four POCT immunoassay kits of CK-MB, MYO, cTnI and NT-proBNP
- Categories:Company News
- Author:
- Origin:
- Time of issue:2021-09-23 14:16
- Views:
(Summary description)April 24, 2014, Lumigenex announced today that it had received certificates of registration from CFDA for four POCT immunoassay kits
CFDA for four POCT immunoassay kits of CK-MB, MYO, cTnI and NT-proBNP
(Summary description)April 24, 2014, Lumigenex announced today that it had received certificates of registration from CFDA for four POCT immunoassay kits
- Categories:Company News
- Author:
- Origin:
- Time of issue:2021-09-23 14:16
- Views:
April 24, 2014, Lumigenex announced today that it had received certificates of registration from CFDA for four POCT immunoassay kits: Creatine Kinase (CK-MB) quantitative detection kit (time-resolved fluorescence immunochromatographic assay); Myoglobin (MYO) quantitative detection kit ((time-resolved fluorescence immunochromatographic assay); cardiac troponin I (cTnI) quantitative detection kit ((time-resolved fluorescence immunochromatographic assay); N-terminal brain natriuretic peptide (NT-proBNP) quantitative detection kit ((time-resolved fluorescence immunochromatographic assay).
底部版权信息
Copyright©2021 Lumigenex (Suzhou) Co., Ltd. All Rights Reserved. Website construction: www.300.cn